Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;93(7):1083-95.
doi: 10.1007/s00277-014-2086-0. Epub 2014 Apr 29.

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Olaf Penack  1 , Carolin Becker, Dieter Buchheidt, Maximilian Christopeit, Michael Kiehl, Marie von Lilienfeld-Toal, Marcus Hentrich, Marc Reinwald, Hans Salwender, Enrico Schalk, Martin Schmidt-Hieber, Thomas Weber, Helmut Ostermann
Affiliations
Review

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Olaf Penack et al. Ann Hematol. 2014 Jul.

Abstract

Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optimal management may differ between neutropenic and non-neutropenic patients. Our aim is to give evidence-based recommendations for haematologist, oncologists and intensive care physicians on how to manage adult patients with neutropenia and sepsis.

PubMed Disclaimer

References

    1. Aarts MJ, Peters FP, Mandigers CM et al. (2013) Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia. J Clin Oncol 31(34):4290–4296 - PubMed
    1. Abeyama K, Stern DM, Ito Y, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest. 2005;115:1267–1274. - PMC - PubMed
    1. Adda M, Coquet I, Darmon M, et al. Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med. 2008;36:2766–2772. - PubMed
    1. Afshari A, Wetterslev J, Brok J et al. (2008) Antithrombin III for critically ill patients. Cochrane Database Syst Rev 16(3):CD005370 - PubMed
    1. Ahn S, Lee YS, Chun YH, et al. Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia. Support Care Cancer. 2011;19:1151–1158. - PubMed